103 related articles for article (PubMed ID: 20237749)
1. [Timing of initiation of antiretroviral therapy in HIV-1-infected patients. Meta-analysis of the When To Start Consortium].
Goebel FD; Nitschmann S
Internist (Berl); 2010 Apr; 51(4):539-41. PubMed ID: 20237749
[No Abstract] [Full Text] [Related]
2. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
3. Should the CD4 threshold for starting ART be raised?
Wood R; Lawn SD
Lancet; 2009 Apr; 373(9672):1314-6. PubMed ID: 19361856
[No Abstract] [Full Text] [Related]
4. HIV news from Buenos Aires: Part 1--the Zahir and the band-aid. 1st IAS conference on HIV pathogenesis and treatment. July 8-11, 2001, Buenos Aires.
Mascolini M
IAPAC Mon; 2001 Sep; 7(9):274-89. PubMed ID: 11708272
[No Abstract] [Full Text] [Related]
5. Antiretroviral therapy for HIV: drug resistance and sequencing.
Burkle WS
J Assoc Nurses AIDS Care; 2002; 13(1):76-80. PubMed ID: 11828862
[No Abstract] [Full Text] [Related]
6. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians.
Mekonnen Y; Dukers NH; Sanders E; Dorigo W; Wolday D; Schaap A; Geskus RB; Coutinho RA; Fontanet A
Ethiop Med J; 2003 Jun; 41 Suppl 1():61-5. PubMed ID: 15227882
[TBL] [Abstract][Full Text] [Related]
7. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
8. HIV therapeutics: points from the recent literature.
Laurence J
AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
[No Abstract] [Full Text] [Related]
9. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
[TBL] [Abstract][Full Text] [Related]
10. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
11. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.
Zhyvytsia D
Georgian Med News; 2014; (232-233):69-74. PubMed ID: 25214276
[TBL] [Abstract][Full Text] [Related]
12. Salvage therapy for HIV infection: when and how.
Núñez M; Soriano V
AIDS Patient Care STDS; 2000 Sep; 14(9):465-76. PubMed ID: 11051629
[No Abstract] [Full Text] [Related]
13. Patients who want to stop their medications: treatment interruptions in HIV infection.
Ball SC
AIDS Read; 2003 Jul; 13(7):317-9, 324, 342. PubMed ID: 12889449
[No Abstract] [Full Text] [Related]
14. Assessment of the prognostic value of the World Health Organization clinical staging system for HIV/AIDS in HIV-infected children and adolescents in a cohort in Belo Horizonte, Brazil.
Cardoso CA; Pinto JA; Candiani TM; Carvalho IR; Dantas AG; Goulart EM
J Trop Pediatr; 2012 Oct; 58(5):353-9. PubMed ID: 22238136
[TBL] [Abstract][Full Text] [Related]
15. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
[TBL] [Abstract][Full Text] [Related]
16. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
; Ray M; Logan R; Sterne JA; Hernández-Díaz S; Robins JM; Sabin C; Bansi L; van Sighem A; de Wolf F; Costagliola D; Lanoy E; Bucher HC; von Wyl V; Esteve A; Casbona J; del Amo J; Moreno S; Justice A; Goulet J; Lodi S; Phillips A; Seng R; Meyer L; Pérez-Hoyos S; García de Olalla P; Hernán MA
AIDS; 2010 Jan; 24(1):123-37. PubMed ID: 19770621
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
Antiretroviral Therapy Cohort Collaboration (ART-CC)
Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study.
Angriman F; Belloso WH; Sierra-Madero J; Sánchez J; Moreira RI; Kovalevski LO; Orellana LC; Cardoso SW; Crabtree-Ramirez B; La Rosa A; Losso MH
Int J STD AIDS; 2016 Feb; 27(2):118-26. PubMed ID: 25740759
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
